IS4452A - Bísýklískar amidínafleiður sem eru gagnlegar við læknismeðhöndlun - Google Patents

Bísýklískar amidínafleiður sem eru gagnlegar við læknismeðhöndlun

Info

Publication number
IS4452A
IS4452A IS4452A IS4452A IS4452A IS 4452 A IS4452 A IS 4452A IS 4452 A IS4452 A IS 4452A IS 4452 A IS4452 A IS 4452A IS 4452 A IS4452 A IS 4452A
Authority
IS
Iceland
Prior art keywords
medical treatment
derivatives useful
amidine derivatives
bicyclic amidine
bicyclic
Prior art date
Application number
IS4452A
Other languages
English (en)
Icelandic (is)
Inventor
Edwin Mcdonald James
Russell Matz James
John Murray Robert
Calvin Shakespeare William
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4452A publication Critical patent/IS4452A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS4452A 1995-08-10 1997-03-25 Bísýklískar amidínafleiður sem eru gagnlegar við læknismeðhöndlun IS4452A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1995/001896 WO1997006158A1 (en) 1995-08-10 1995-08-10 Bicyclic amidine derivatives useful in therapy

Publications (1)

Publication Number Publication Date
IS4452A true IS4452A (is) 1997-03-25

Family

ID=10768883

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4452A IS4452A (is) 1995-08-10 1997-03-25 Bísýklískar amidínafleiður sem eru gagnlegar við læknismeðhöndlun

Country Status (7)

Country Link
KR (1) KR970706272A (cs)
BR (1) BR9509297A (cs)
CZ (1) CZ287969B6 (cs)
EE (1) EE9700207A (cs)
IS (1) IS4452A (cs)
SK (1) SK281442B6 (cs)
WO (1) WO1997006158A1 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701681D0 (sv) * 1997-05-05 1997-05-05 Astra Ab New compounds
US6166030A (en) * 1997-05-05 2000-12-26 Astra Aktiebolag Compounds
DE19844291A1 (de) * 1998-09-18 2000-03-23 Schering Ag Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
SE9803710L (sv) 1998-09-25 2000-03-26 A & Science Invest Ab Användning av vissa substanser för behandling av nervrotsskador
US7115557B2 (en) 1998-09-25 2006-10-03 Sciaticon Ab Use of certain drugs for treating nerve root injury
EP1283199A4 (en) 2000-05-16 2003-12-17 Takeda Chemical Industries Ltd MELANINE CONCENTRATING HORMONE ANTAGONISTS
TWI243164B (en) 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
MY136316A (en) 2001-02-13 2008-09-30 Sanofi Aventis Deutschland Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical.
DE60325025D1 (de) 2002-02-15 2009-01-15 Glaxo Group Ltd Modulatoren des vanilloidrezeptors
EP1388535A1 (en) * 2002-08-07 2004-02-11 Aventis Pharma Deutschland GmbH Acylated arylcycloalkylamines and their use as pharmaceuticals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0690851B1 (en) * 1993-03-23 1999-05-19 Astra Aktiebolag Guanidine derivatives useful in therapy
ATE231126T1 (de) * 1993-08-12 2003-02-15 Astrazeneca Ab Amidin-derivate mit stickstoffoxid-synthease- aktivität
JPH10500138A (ja) * 1994-05-07 1998-01-06 アストラ・アクチエボラーグ 酸化窒素合成酵素阻害剤としての2環アミジン誘導体

Also Published As

Publication number Publication date
SK39097A3 (en) 1998-08-05
EE9700207A (et) 1998-02-16
CZ287969B6 (cs) 2001-03-14
BR9509297A (pt) 1998-07-07
KR970706272A (ko) 1997-11-03
SK281442B6 (sk) 2001-03-12
WO1997006158A1 (en) 1997-02-20
CZ108697A3 (cs) 1998-04-15

Similar Documents

Publication Publication Date Title
DE69623722D1 (de) Blutbehandlungsgerät
BR9605861A (pt) Tratamento de vegetais
ATE182266T1 (de) An den körper anschmiegender absorbierender artikel
IS1852B (is) Spíró-asabísýklísk efnasambönd sem eru gagnleg við meðferð
DE69614680D1 (de) Implantierbare osteosynthesevorrichtung
BR9305642A (pt) Implantes subcutàneos baseados em derivados de nomegestrol
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
DE69320523D1 (de) Menschliche Körper-Detektionsanordnung
DE19681419T1 (de) Behandlungssystem
EE03439B1 (et) Teraapias kasutatavad bitsüklilised isotiokarbamiidi derivaadid
IS4452A (is) Bísýklískar amidínafleiður sem eru gagnlegar við læknismeðhöndlun
IL133088A0 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
DE59301768D1 (de) Zahnbehandlungseinheit
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
FR2737549B1 (fr) Brancard inferieur de carrosserie
BR9702075A (pt) Derivados de uréida biologicamente ativos úteis no tratamento de esclerose múltipla
NO972896D0 (no) Medisinsk artikkel
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
TR199501363A2 (tr) Tedavide kullanisli bisiklik amidin türevleri.
GB9526264D0 (en) Medical treatment
KR960030492U (ko) 의료용 멸균기
ZA96972B (en) Bicyclic isothiourea derivatives useful in therapy
GB2307858B (en) Medical treatment